Autonomix Medical, Inc.
AMIX· Nasdaq
Released May 31, 2024, after the close
10-K filed May 31, 2024, 61 days after period end · 0001437749-24-018932
| Metric | Q4 2024 | Q4 2023dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$15.43M | -$657.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Autonomix Medical, Inc. · CIK 1617867 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 31, 2024 · 61 d after period end